http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1007504-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e417e4a32a6ec42f403339bbea8f138e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C227-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1998-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ae79a7b6de82086715e18a8462e4364
publicationDate 2000-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1007504-A1
titleOfInvention Sterilized 5-aminolevulinic acid
abstract Colored 5-aminolevulinic acid crystals useful for photodynamic therapy Eire disclosed. Preferably the colored 5-aminolevulinic acid crystals have the color imparted by irradiation of the crystals, such as gamma radiation. The colored ALA crystals are preferably pharmaceutically pure and sterile and can be contained in a sealed sterile container. Also disclosed is sterile aqueous ALA solution which includes the colored ALA crystals contained in water. Also disclosed is a method for preparing colored ALA crystals which includes exposing non-irradiated ALA crystals to a radiation source at a dose sufficient impart a color which is different than any color present in the non-irradiated crystals. Preferably the irradiation is sufficient to sterilize the ALA crystals. The sterile colored ALA crystals can be used in a kit for internal or external treatment and/or detection of a condition in a mammal, which includes the sterile, colored ALA crystals and sterile diluent, and in the case of internal treatment and/or detection optionally a catheter for administration of the ALA.
priorityDate 1997-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53905969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5481287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226551551
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230568764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232353599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136187588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18329477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135577896

Total number of triples: 33.